Literature DB >> 29094082

Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala.

Anna Gottschlich1, Alvaro Rivera-Andrade1, Edwin Grajeda1, Christian Alvarez1, Carlos Mendoza Montano1, Rafael Meza1.   

Abstract

PURPOSE: Cervical cancer rates in Latin America are higher than those in developed countries, likely because of the lower prevalence of screening. Specifically, less than 40% of women in Guatemala are regularly screened and even fewer women are screened in indigenous communities. Current screening strategies-Pap smears and visual inspection with acetic acid-might not be the most effective methods for controlling cancer in these settings. We thus investigated the potential of self-collection of cervical samples with testing for human papillomavirus (HPV) to help prevent cervical cancer in an indigenous community in Guatemala. PATIENTS AND METHODS: A community representative random sample of 202 indigenous women age 18 to 60 years residing in Santiago Atitlan, Guatemala, were surveyed to assess knowledge of and risk factors for HPV and cervical cancer. Women were then invited to self-collect a cervical sample using HerSwab collection kits to assess the prevalence of HPV and the acceptability of self-sampling.
RESULTS: Of 202 women who completed the survey, 178 (89%) provided a self-sample. In all, 79% of these women found the test comfortable, 91% found the test easy to use, and 100% reported they were willing to perform the test periodically as a screening method. Thirty-one samples (17%) were positive for at least one of 13 high-risk HPV types, and eight (4.5%) were positive for HPV 16/18.
CONCLUSION: HPV testing by using self-collected samples was well accepted, suggesting that it is a plausible modality for cervical cancer screening in indigenous communities. Further studies are needed to assess rates of follow-up after a positive test and to determine whether these findings extend to other indigenous and nonindigenous communities in Guatemala and Latin America.

Entities:  

Year:  2017        PMID: 29094082      PMCID: PMC5646882          DOI: 10.1200/JGO.2016.005629

Source DB:  PubMed          Journal:  J Glob Oncol        ISSN: 2378-9506


  35 in total

1.  Cervical cancer in the developing world.

Authors:  J Sherris; C Herdman; C Elias
Journal:  West J Med       Date:  2001-10

2.  High prevalence of human papillomavirus infection in the female population of Guatemala.

Authors:  Xavier Vallès; Gladys Beatriz Murga; Gabriela Hernández; Meritxell Sabidó; Alejandro Chuy; Belén Lloveras; Francesc Alameda; Sílvia de San José; Francesc Xavier Bosch; Isabel Pedroza; Xavier Castellsagué; Jordi Casabona
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

3.  A review of human carcinogens--Part B: biological agents.

Authors:  Véronique Bouvard; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

4.  A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

Authors:  You-Lin Qiao; John W Sellors; Paul S Eder; Yan-Ping Bao; Jeanette M Lim; Fang-Hui Zhao; Bernhard Weigl; Wen-Hua Zhang; Roger B Peck; Ling Li; Feng Chen; Qing-Jing Pan; Attila T Lorincz
Journal:  Lancet Oncol       Date:  2008-09-19       Impact factor: 41.316

5.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 6.  Effective screening programmes for cervical cancer in low- and middle-income developing countries.

Authors:  R Sankaranarayanan; A M Budukh; R Rajkumar
Journal:  Bull World Health Organ       Date:  2001-11-01       Impact factor: 9.408

7.  Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.

Authors:  Laia Bruni; Mireia Diaz; Xavier Castellsagué; Elena Ferrer; F Xavier Bosch; Silvia de Sanjosé
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

8.  Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.

Authors:  Maria Benevolo; Amina Vocaturo; Donatella Caraceni; Deborah French; Sandra Rosini; Roberta Zappacosta; Irene Terrenato; Lucia Ciccocioppo; Antonio Frega; Paolo Giorgi Rossi
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

9.  Body mass index, socio-economic status and socio-behavioral practices among Tz'utujil Maya women.

Authors:  Jason M Nagata; Claudia R Valeggia; Frances K Barg; Kent D W Bream
Journal:  Econ Hum Biol       Date:  2009-02-23       Impact factor: 2.184

Review 10.  Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.

Authors:  Jack Cuzick; Marc Arbyn; Rengaswamy Sankaranarayanan; Vivien Tsu; Guglielmo Ronco; Marie-Helene Mayrand; Joakim Dillner; Chris J L M Meijer
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

View more
  19 in total

1.  Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.

Authors:  Philip E Castle; Vânia R S Silva; Marcia E L Consolaro; Nádia Kienen; Lorna Bittencourt; Sandra M Pelloso; Edward E Partridge; Amanda Pierz; Camila B Dartibale; Nelson S Uchimura; Isabel C Scarinci
Journal:  Cancer Prev Res (Phila)       Date:  2019-01-16

2.  DNA concentration from self samples for HPV testing.

Authors:  Rafael Meza; Yan Kwan Lau; Trey B Thomas; Thomas E Carey; Heather M Walline; Marisa C Eisenberg
Journal:  Int J Cancer       Date:  2018-10-03       Impact factor: 7.396

3.  Acceptability of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening in a Cohort of Patients from Romania (Stage 2).

Authors:  Mihaela Grigore; Ingrid-Andrada Vasilache; Petru Cianga; Daniela Constantinescu; Odetta Duma; Roxana Daniela Matasariu; Ioana-Sadiye Scripcariu
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

4.  HPV self-sampling for cervical cancer screening: a systematic review of values and preferences.

Authors:  Holly Nishimura; Ping Teresa Yeh; Habibat Oguntade; Caitlin E Kennedy; Manjulaa Narasimhan
Journal:  BMJ Glob Health       Date:  2021-05

Review 5.  Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.

Authors:  Sarah Gupta; Christina Palmer; Elisabeth M Bik; Juan P Cardenas; Harold Nuñez; Laurens Kraal; Sara W Bird; Jennie Bowers; Alison Smith; Nathaniel A Walton; Audrey D Goddard; Daniel E Almonacid; Susan Zneimer; Jessica Richman; Zachary S Apte
Journal:  Front Public Health       Date:  2018-04-09

6.  Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.

Authors:  Sandra Y Oketch; Zachary Kwena; Yujung Choi; Konyin Adewumi; Michelle Moghadassi; Elizabeth A Bukusi; Megan J Huchko
Journal:  BMC Womens Health       Date:  2019-06-13       Impact factor: 2.809

7.  Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.

Authors:  Hong Lou; Eduardo Gharzouzi; Sarita Polo Guerra; Joël Fokom Domgue; Julie Sawitzke; Guillermo Villagran; Lisa Garland; Joseph F Boland; Sarah Wagner; Héctor Rosas; Jami Troxler; Heidi McMillen; Bailey Kessing; Enrique Alvirez; Miriam Castillo; Hesler Morales; Victor Argueta; Andert Rosingh; Femke J H B van Aerde-van Nunen; Griselda Lopez; Herbert M Pinedo; Mark Schiffman; Michael Dean; Roberto Orozco
Journal:  BMC Cancer       Date:  2018-05-15       Impact factor: 4.430

8.  Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.

Authors:  Anna Gottschlich; Alvaro Rivera-Andrade; Kristin Bevilacqua; Audrey R Murchland; Ergest Isak; Christian S Alvarez; Gina Ogilvie; Thomas E Carey; Mark Prince; Michael Dean; Carlos Mendoza-Montano; Rafael Meza
Journal:  BMC Public Health       Date:  2020-09-15       Impact factor: 3.295

9.  Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study.

Authors:  Marisa C Eisenberg; Lora P Campredon; Andrew F Brouwer; Heather M Walline; Brittany M Marinelli; Yan Kwan Lau; Trey B Thomas; Rachel L Delinger; Taylor S Sullivan; Monica L Yost; Christine M Goudsmit; Thomas E Carey; Rafael Meza
Journal:  BMJ Open       Date:  2018-10-02       Impact factor: 2.692

10.  Barriers to Cervical Cancer Screening and the Cervical Cancer Care Continuum in Rural Guatemala: A Mixed-Method Analysis.

Authors:  Kirsten Austad; Anita Chary; Sandy Mux Xocop; Sarah Messmer; Nora King; Lauren Carlson; Peter Rohloff
Journal:  J Glob Oncol       Date:  2018-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.